About the Journal
Focus and Scope
European Atherosclerosis Journal is an international, peer-reviewed, fully open access, four-monthly international journal that
publishes papers in the field of atherosclerosis and cardiovascular disease, from basic research to clinical and translational studies. Meta-analysis and systematic reviews will also be accepted. Papers will be considered for publication based on originality and contribution to the field. The journal will consider for publication original articles (experimental and clinical), review articles, methodology papers, editorials, letters to the Editor, viewpoints, congress/conference reports. The Editorial Board can invite authors to submit state-of-the-art papers. Authors are encouraged to submit pre-request to the Editor-in-Chief for evaluation of the potential acceptability of their contributions.
Open Access Policy
European Atherosclerosis Journal provides immediate open access to its content on the principle that making research freely available to the public supports exchange of knowledge.
Article Processing Charge
Publishing an article in European Atherosclerosis Journal requires the payment of an Article Processing Charge (APC) of € 2,000. There are no charges for submission, rejected articles, or color figures. Payment can be made by bank transfer. Invoices will be emailed by the editorial assistant shortly after acceptance of the paper to the payment contact provided by the authors at the time of submission.
Peer Review Process
Immediately after submission, the Editor-in-Chief evaluates the manuscript. The Editor can accept the paper at this stage after discussing with members of the Editorial Board. Rejection at this stage may occur if the submitted manuscript is insufficiently original, has serious scientific flaws, has poor grammar or English language, or is outside the aims and scope of the Journal. A manuscript that meets the minimum criteria will be reviewed by at least 2 expert reviewers. Suggestions for potential reviewers from the authors are welcome, but it is the Editor's decision whether or not to follow such suggestions.
Reviewers will evaluate the manuscript according to the following criteria:
- Originality (the main results and conclusions must not have been published or under consideration elsewhere);
- Method appropriateness;
- Validity of data and clarity of result presentation;
- Conclusions consistency with the evidence and arguments presented;
- Updated and proper references.
Reviewers will not copyedit manuscripts. Language corrections can be suggested during peer review process.
The final decision is made by the Editor-in-Chief.
Code of conduct
Editors, authors, and reviewers must follow the best practice in publication ethics. Authors are expected to respect rules on authorship, dual or overlapping submission, plagiarism, figure manipulation, conflicts of interest, and compliance with policies on research ethics. Reviewers and Editors must treat manuscripts impartially and in confidence, and declare any competing interests. The Editor-in-Chief can contact authors’ institutions, funders or regulatory bodies, if required. In the presence of a proven misconduct, the Journal will take actions to correct the scientific record, which may include either issuing a correction or paper retraction. If you have any concerns about potential misconduct, please contact the Editor-in-Chief.
Published by SITeCS under a Creative Commons license
All content published in European Atherosclerosis Journal is licensed under a Creative Commons Attribution Non-Commercial No Derivatives license (CC BY-NC-ND)
© The Author(s). Published by SITeCS
Copyright retained by the author but commercial rights transferred to the publisher. For commercial re-use please contact the Editorial Office.